A 6-year survey of HFE gene test for hemochromatosis diagnosis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15654232.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 6-year survey of HFE gene test was conducted to evaluate its helpfulness for hereditary hemochromatosis diagnosis. We analyzed C282Y, H63D, and S65C mutations on 3525 individuals. The test produced 89.7% and 30% of positive results for individuals clinically diagnosed hemochromatosis before HFE gene-test availability and those prospectively tested because of elevated serum iron parameter and/or family history, respectively; among them there were 90.4% and 48.7% of C282Y homozygotes. The HFE gene test confirmed a genetic defect that may lead to iron loading in individuals when iron parameter values, especially for the C282Y/C282Y, were still low as well as for genotypes usually associated with low expressivity and penetrance (C282Y/H63D, H63D/H63D). This gene-test should allow a biochemical follow-up of patients carrying a disease-related genotype.
Medical subject headings
- Amino Acid Substitution
- DNA Mutational Analysis
- Hemochromatosis
- Histocompatibility Antigens Class I
- Membrane Proteins
- Molecular Diagnostic Techniques
- Point Mutation